SCHEMBL6776087

SCHEMBL6776087

CCCCCn1cc(C2CCN(CCCC(O)c3ccc(C(C)(C)C(=O)O)cc3)CC2)c2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.59
HRH1 P35367 3/20 0.59
DRD3 P35462 3/20 0.59
HTR2A P28223 3/20 0.59
HTR2B P41595 3/20 0.59
KCNH2 Q12809 3/20 0.59
BLM P54132 2/20 0.59
CNR1 P21554 1/20 0.59
APEX1 P27695 1/20 0.59
PDE4A P27815 1/20 0.59
PDE3A Q14432 1/20 0.59
DRD2 P14416 2/20 0.58
ALOX15 P16050 1/20 0.58
HSD17B10 Q99714 1/20 0.58
HRH2 P25021 8/20 0.53
HTR2C P28335 2/20 0.49
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
CACNA1F O60840 1/20 0.47
GMNN O75496 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6782586 0.90 HRH2 (0.59) LMNAHRH1DRD3HTR2AHTR2B
SCHEMBL6777203 0.89 HTR2A (0.56) LMNAHRH1DRD3HTR2AHTR2B
SCHEMBL6777709 0.85 LMNA (0.56) LMNAHRH1DRD3HTR2AHTR2B
SCHEMBL7703139 0.81 HRH2 (0.50) HTR2AHTR2BHRH2HTR2C
SCHEMBL6782119 0.80 HRH2 (0.64) HTR2AHTR2BHRH2HTR2C
SCHEMBL6781803 0.79 HRH2 (0.65) HTR2AHTR2BHRH2HTR2C
SCHEMBL6785790 0.78 HRH2 (0.49) LMNAHRH1DRD3HTR2AHTR2B
SCHEMBL6782829 0.78 HRH2 (0.46) HTR2AHTR2BDRD2HRH2HTR2C
SCHEMBL1967057 0.77 HRH1 (0.73) LMNAHRH1DRD3HTR2AHTR2B
SCHEMBL6775396 0.77 HRH2 (0.67) HTR2AHTR2BHRH2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183251-B1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA SA (ES) 2004-02-11 EP claimed
US-6683096-B2 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2004-01-27 US claimed
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2002-10-10 US claimed
EP-1183251-B1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA SA (ES) 2004-02-11 EP disclosed
US-6683096-B2 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2004-01-27 US disclosed
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents ALMIRALL PRODESFARMA, S.A. (ES) 2002-10-10 US disclosed
EP-1183251-A1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS Almirall Prodesfarma, S.A. (ES) 2002-03-06 EP disclosed
WO-2000075130-A1 INDOLYLPIPERIDINE DERIVATIVES AS ANTIHISTAMINIC AND ANTIALLERGIC AGENTS ALMIRALL PRODESFARMA, S.A. (ES) 2000-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147344-A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents HRH2, HRH1, HRH4 LMNA 4761/4885HRH1 2/4885DRD3 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.